Neurobiology of Disease Volume 162 to 175

Neurobiology of Disease stands as a prominent international open access journal positioned at the crossroads of fundamental and clinical neuroscience. Within this dynamic space, the journal serves as a pivotal platform for disseminating high-caliber research that bridges the gap between basic scientific insights and their clinical implications.

The journal’s scope spans a diverse range of crucial areas in neuroscience research, including but not limited to:

1. Molecular and Cellular Disease Mechanisms: Exploring the intricate molecular and cellular pathways that underlie the development and progression of various neurological and psychiatric disorders. These investigations delve into the fundamental biological mechanisms at play.
2. Neural Systems and Behavioral Disorders: Investigating the interplay between neural systems and the resulting behavioral abnormalities, shedding light on the complex relationships between brain function and clinical manifestations.
3. Genetics of Neurological and Psychiatric Diseases: Unveiling the genetic underpinnings of inherited neurological and psychiatric conditions, contributing to our understanding of the hereditary aspects of these disorders.
4. Nervous System Aging: Addressing the challenges associated with nervous system aging, including the changes that occur at the cellular and molecular levels, as well as their implications for cognitive health and neurodegenerative diseases.
5. Therapeutic Development and Neurobiology: Focusing on findings with direct relevance to the development of novel therapies for neurological and psychiatric disorders. Importantly, the journal seeks studies that deepen our understanding of the neurobiology underlying these conditions and inform the development of effective treatments.

The emphasis of Neurobiology of Disease lies in publishing research that not only advances our knowledge of disease mechanisms but also holds potential for informing therapeutic strategies. In this regard, the journal does not prioritize the validation of potential therapeutics unless they contribute significantly to expanding our understanding of the underlying neurobiology.

By offering open access to its content, Neurobiology of Disease ensures that these crucial insights are accessible to a global audience of researchers, clinicians, and professionals committed to advancing our understanding of neurological and psychiatric disorders.

Volume 162: January 2022

Volume 163: February 2022

Volume 164: March 2022

Volume 165: April 2022

Volume 166: May 2022

Volume 167: 1 June 2022

Volume 168: 15 June 2022

Volume 169: July 2022

Volume 170: August 2022

Volume 171: September 2022

Volume 172: 1 October 2022

Volume 173: 15 October 2022

Volume 174: November 2022

Volume 175: December 2022